Cargando…

The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer

Only a few investigations, to our knowledge, have examined the bioenergetics of Tamoxifen (TMX) resistant individuals and reported altered mitochondrial activity and metabolic profile. The primary cause of TMX resistance is firmly suggested to be metabolic changes. Metabolic variations and hypoxia h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azzam, Hany N., El-Derany, Marwa O., Wahdan, Sara A., Faheim, Reham M., Helal, Gouda K., El-Demerdash, Ebtehal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587280/ https://www.ncbi.nlm.nih.gov/pubmed/37646973 http://dx.doi.org/10.1007/s13577-023-00977-5

Ejemplares similares

Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
por: Azzam, Hany N., et al.
Publicado: (2022)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
por: El-Derany, Marwa O.
Publicado: (2020)

Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance
por: El Mesallamy, Hala O, et al.
Publicado: (2010)

Sodium Selenite Improves Folliculogenesis in Radiation-Induced Ovarian Failure: A Mechanistic Approach
por: Said, Riham S., et al.
Publicado: (2012)

Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo
por: El-Derany, Marwa O., et al.
Publicado: (2021)

The role of Nanog expression in tamoxifen-resistant breast cancer cells
por: Arif, Khalid, et al.
Publicado: (2015)

Growth Hormone Ameliorates the Radiotherapy-Induced Ovarian Follicular Loss in Rats: Impact on Oxidative Stress, Apoptosis and IGF-1/IGF-1R Axis
por: Mahran, Yasmen F., et al.
Publicado: (2015)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms
por: El-Derany, Marwa O., et al.
Publicado: (2022)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
por: Vafeiadou, Vasiliki, et al.
Publicado: (2022)

Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)

Targeting TNF-α and NF-κB Activation by Bee Venom: Role in Suppressing Adjuvant Induced Arthritis and Methotrexate Hepatotoxicity in Rats
por: Darwish, Samar F., et al.
Publicado: (2013)

Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study
por: Abdelmageed, Mai M., et al.
Publicado: (2016)

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
por: Steifensand, Friederike, et al.
Publicado: (2021)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-β, TGF-β, and FOXL-2
por: Haddad, Yasmin Hamdy, et al.
Publicado: (2020)

Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study
por: Hakim, Sarah Adel, et al.
Publicado: (2021)

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
por: Shatta, Mahmoud A., et al.
Publicado: (2022)

Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
por: Fiorillo, Marco, et al.
Publicado: (2017)

Multimechanistic Antifibrotic Effect of Biochanin A in Rats: Implications of Proinflammatory and Profibrogenic Mediators
por: Breikaa, Randa M., et al.
Publicado: (2013)

Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways
por: Mantawy, Eman M., et al.
Publicado: (2017)

Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer
por: Moin, Afrasim, et al.
Publicado: (2021)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer
por: Feng, Qin, et al.
Publicado: (2014)

Molecular mechanisms and mode of tamoxifen resistance in breast cancer
por: Ali, Shazia, et al.
Publicado: (2016)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
por: Yao, Jingwei, et al.
Publicado: (2020)

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
por: Bekele, Raie T., et al.
Publicado: (2016)

atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis
por: Algammal, Abdelazeem M., et al.
Publicado: (2021)

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
por: Woo, Hye In, et al.
Publicado: (2017)

The Effects of Tamoxifen in Combination with Tranilast on CXCL12-CXCR4 Axis and Invasion in Breast Cancer Cell Lines
por: Darakhshan, Sara, et al.
Publicado: (2014)

The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients
por: Zamzam, Yomna, et al.
Publicado: (2021)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells
por: Hany, Dina, et al.
Publicado: (2023)

SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells
por: Jin, Ming Li, et al.
Publicado: (2022)

Development and characterization of a tamoxifen-resistant breast carcinoma xenograft
por: Naundorf, H, et al.
Publicado: (2000)

Sox2 promotes tamoxifen resistance in breast cancer cells
por: Piva, Marco, et al.
Publicado: (2014)

TROP2 methylation and expression in tamoxifen-resistant breast cancer
por: Zimmers, Stephanie M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_edh7e8r9isiohgqddcjm0bhupk